BPC-157 (Body Protection Compound-157) is a stable gastric pentadecapeptide derived from human gastric juice. In tablet form, it has been studied for its potential oral bioavailability and systemic activity. Research indicates BPC-157 may support angiogenesis, collagen synthesis, and tissue regeneration, while offering protective effects for the gastrointestinal tract, liver, tendons, and ligaments. Studies suggest it can accelerate recovery from injuries, reduce inflammation, and improve healing of muscle and connective tissue. Oral tablet delivery offers a convenient route of administration for ongoing investigations into systemic effects and therapeutic potential.



